Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
4.540
+0.030 (0.67%)
At close: May 22, 2026, 4:00 PM EDT
5.00
+0.46 (10.13%)
After-hours: May 22, 2026, 5:00 PM EDT
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $99.05 million as of May 22, 2026. Its market cap has decreased by -57.05% in one year.
Market Cap
99.05M
Enterprise Value
7.53M
1-Year Change
-57.05%
Ranking
Category
Stock Price
$4.54
Market Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $99.05M, a decrease of -71.05%. That is a compound annual growth rate of -62.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 98.39M | -65.57% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edesa Biotech | 97.12M |
| ProMIS Neurosciences | 96.76M |
| Biomea Fusion | 96.16M |
| Q32 Bio | 96.14M |
| Oncolytics Biotech | 95.23M |
| Seer, Inc. | 94.79M |
| Aldeyra Therapeutics | 93.50M |
| PolyPid | 92.55M |